-
Most Popular
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
Why Is Soligenix (SNGX) Stock Up 296% Today?
Soligenix stock is up on Tuesday with heavy trading of SNGX shares alongside positive clinical trial data from the company.
3 Growth Stocks Even ‘Permabull’ Cathie Wood Is Selling
Cathie Wood's ARK Invest has been trimming positions in these three high-growth stocks, signaling potential risks ahead for investors.
Why Is Helen Of Troy (HELE) Stock Down 25% Today?
Helen Of Troy stock is taking a beating on Tuesday as HELE investors react to lackluster earnings and lowered outlooks in its Q1 report.
Why Is Indivior (INDV) Stock Down 37% Today?
Indivior stock is down on Tuesday as INDV investors react to a business update that includes lowered outlooks for Q2 and 2024.
3 Bargain Bin Stocks with Millionaire-Maker Potential
Three bargain stocks with substantial upside from potential price-to-earnings multiple reratings and accretive buybacks.
Why Is Anew Medical (WENA) Stock Up 51% Today?
Anew Medical stock is up on Tuesday alongside heavy trading of WENA shares after the company announced development plans.
The 7 Best Warren Buffett Stocks to Buy in July 2024
Some investors may say value investing is dead, but its never a bad time to look at some of the best Warren Buffett stocks to buy
7 Pot Stock Pioneers Poised for High Returns
Explore pioneering pot stocks offering potential for high returns as the cannabis market expands globally. These companies are growing fast!
3 Breakout Stocks to Buy Before They Make Headlines
Explore three breakout stocks for potential growth and profitability in life sciences tools, semiconductors, and industrial machinery.
3 Cannabis Stocks Ready to Blaze as Regulations Ease
These are three of the best cannabis stocks to watch as the federal government reclassifies the drug from Schedule I to Schedule III.
7 Cheap Biotech Stocks With Major Upside Potential
While the broader healthcare sector enjoys permanent relevance, you can potentially maximize your upside with cheap biotech stocks.
3 Longevity Stocks to Buy for Anti-Aging Breakthroughs
Longevity stocks are at the forefront of combating age-related illnesses with transformative AI-driven drug discovery.
3 Healthcare Stocks to Sell in July Before They Crash & Burn
Many healthcare names are attractive. But drugstore chains and some drug makers have poor outlooks. Here are three healthcare stocks to sell.
3 High-Yield REITs to Buy for Steady Income in a Volatile Market
Uncover the potential of high-yield REIT investments, leveraging unique real estate strategies and solid financial health for robust returns.
3 Cannabis Stocks to Buy Ahead of the 2024 Presidential Election
Let’s focus on some of the top cannabis stocks to buy that are likely to see higher highs, especially on Florida’s potential legalization.
GRFS Stock Alert: Grifols Pops 20% on Takeover Interest
Grifols stock is up on Monday as the founding family of the company has presented a preliminary takeover offer for GRFS shares.
Why Is HilleVax (HLVX) Stock Down 87% Today?
HilleVax stock is down on Monday after HLVX investors learned of a failed Phase 2b clinical trial of its norovirus vaccine for infants.
